Shillong: In a significant milestone for cancer prevention in Meghalaya, the first-ever human papillomavirus (HPV)-related cervical pre-cancer treatment using thermal ablation has been successfully performed at the DAE Cancer Wing, Civil Hospital, Shillong. The procedure was carried out by doctors, nurses, and the dedicated team of the Meghalaya Mission Cancer Prevention and Early Detection Project on May 13.
“This achievement signifies a major advancement in strengthening cervical cancer prevention services within the public healthcare system of Meghalaya,” a health official emphasized.
The patient was detected positive for HPV DNA Genotype 11 on March 31, 2026. Following appropriate clinical evaluation, counselling, and assessment, the patient was successfully treated and declared free of cancer.
This breakthrough highlights the effectiveness of thermal ablation as a minimally invasive technique for treating cervical pre-cancer lesions. The procedure is quick, safe, and can be performed in outpatient settings, making it accessible to more women in remote areas.
The Meghalaya Mission Cancer Prevention and Early Detection Project aims to reduce the burden of cervical cancer through screening, vaccination, and timely treatment. With this successful treatment, the project sets a precedent for scaling up similar interventions across the state.
Cervical cancer is the second most common cancer among women in India, but it is largely preventable through HPV vaccination and regular screening. The introduction of thermal ablation in Meghalaya’s public health system is expected to significantly improve early detection and treatment outcomes.
Health officials have urged women to undergo regular cervical cancer screening and to seek timely medical advice if symptoms arise. The success of this procedure is a testament to the collaborative efforts of healthcare professionals and the state government’s commitment to improving women’s health.
